DE3410850A1 - Arzneimittel zum verstaerken von blutgefaessen und dessen verwendung - Google Patents

Arzneimittel zum verstaerken von blutgefaessen und dessen verwendung

Info

Publication number
DE3410850A1
DE3410850A1 DE19843410850 DE3410850A DE3410850A1 DE 3410850 A1 DE3410850 A1 DE 3410850A1 DE 19843410850 DE19843410850 DE 19843410850 DE 3410850 A DE3410850 A DE 3410850A DE 3410850 A1 DE3410850 A1 DE 3410850A1
Authority
DE
Germany
Prior art keywords
acid
diet
ing
fatty acid
blood vessels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19843410850
Other languages
German (de)
English (en)
Inventor
Yasuo Izumo Nara
Yukio Yamori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE3410850A1 publication Critical patent/DE3410850A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19843410850 1983-03-25 1984-03-23 Arzneimittel zum verstaerken von blutgefaessen und dessen verwendung Ceased DE3410850A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58051122A JPS59175425A (ja) 1983-03-25 1983-03-25 脳卒中予防剤

Publications (1)

Publication Number Publication Date
DE3410850A1 true DE3410850A1 (de) 1984-10-04

Family

ID=12877995

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19843410850 Ceased DE3410850A1 (de) 1983-03-25 1984-03-23 Arzneimittel zum verstaerken von blutgefaessen und dessen verwendung

Country Status (4)

Country Link
JP (1) JPS59175425A (it)
DE (1) DE3410850A1 (it)
GB (1) GB2140688B (it)
IT (1) IT1178915B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314105A2 (en) * 1987-10-29 1989-05-03 Takeda Chemical Industries, Ltd. Angiogenesis enhancer

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8505569D0 (sv) * 1985-11-25 1985-11-25 Aco Laekemedel Ab Enteralt preparat
US5198250A (en) * 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
ES2229935B1 (es) * 2003-10-10 2006-10-01 Universitat De Les Illes Balears Utilizacion del acido hidroxioleico y compuestos analagos del mismo como aditivos alimentarios funcionales.

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE880635C (de) * 1951-05-29 1953-06-22 Werner Kloesser Mittel zur Verhuetung der Empfaengnis
DE1468309A1 (de) * 1964-02-18 1969-07-10 Hoerrmann Dr Wilhelm Darstellung von cis- und trans-Pentadecen-(7)-carbonsaeure-(1)- bzw. funktioneller Derivate
DE2460205A1 (de) * 1974-02-09 1975-08-14 Akira Kafuku Arzneimittel zur behandlung der dermatomykose
US3924000A (en) * 1971-02-08 1975-12-02 Geraldine H Thiele Injectable solution
US4166108A (en) * 1977-01-31 1979-08-28 Robert Brown Styptic composition
GB2024010A (en) * 1978-06-28 1980-01-09 Wolff Chem Pharm Gmbh Compositions containing fatty acids for the treatment of seborrhoeic conditions
US4186196A (en) * 1976-04-19 1980-01-29 Lasher Edward Abe Topical anti-fungicide preparation
US4258028A (en) * 1978-05-09 1981-03-24 Cameo, Inc. Method for reducing dental plaque and pellicle precursor of plaque
US4331653A (en) * 1977-08-18 1982-05-25 Robert Brown Composition for a topical cream for curtailing bleeding and treating skin disorders
US4343798A (en) * 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
EP0068552A2 (en) * 1981-06-23 1983-01-05 THE PROCTER & GAMBLE COMPANY Topical antimicrobial composition

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE880635C (de) * 1951-05-29 1953-06-22 Werner Kloesser Mittel zur Verhuetung der Empfaengnis
DE1468309A1 (de) * 1964-02-18 1969-07-10 Hoerrmann Dr Wilhelm Darstellung von cis- und trans-Pentadecen-(7)-carbonsaeure-(1)- bzw. funktioneller Derivate
US3924000A (en) * 1971-02-08 1975-12-02 Geraldine H Thiele Injectable solution
DE2460205A1 (de) * 1974-02-09 1975-08-14 Akira Kafuku Arzneimittel zur behandlung der dermatomykose
US4186196A (en) * 1976-04-19 1980-01-29 Lasher Edward Abe Topical anti-fungicide preparation
US4166108A (en) * 1977-01-31 1979-08-28 Robert Brown Styptic composition
US4331653A (en) * 1977-08-18 1982-05-25 Robert Brown Composition for a topical cream for curtailing bleeding and treating skin disorders
US4258028A (en) * 1978-05-09 1981-03-24 Cameo, Inc. Method for reducing dental plaque and pellicle precursor of plaque
GB2024010A (en) * 1978-06-28 1980-01-09 Wolff Chem Pharm Gmbh Compositions containing fatty acids for the treatment of seborrhoeic conditions
US4343798A (en) * 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
EP0068552A2 (en) * 1981-06-23 1983-01-05 THE PROCTER & GAMBLE COMPANY Topical antimicrobial composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
US-Z.: ZENTNER, G.M. et al.: J. Pharm. Sci., Vol. 70, No. 9, Sept. 1981, S. 975-981 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314105A2 (en) * 1987-10-29 1989-05-03 Takeda Chemical Industries, Ltd. Angiogenesis enhancer
EP0314105A3 (en) * 1987-10-29 1991-04-17 Takeda Chemical Industries, Ltd. Angiogenesis enhancer

Also Published As

Publication number Publication date
JPS59175425A (ja) 1984-10-04
GB8407735D0 (en) 1984-05-02
JPH0136804B2 (it) 1989-08-02
IT8467291A1 (it) 1985-09-26
IT1178915B (it) 1987-09-16
IT8467291A0 (it) 1984-03-26
GB2140688B (en) 1987-02-25
GB2140688A (en) 1984-12-05

Similar Documents

Publication Publication Date Title
DE602004010531T2 (de) Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
DE60022987T2 (de) Fettsäurezusammensetzung, die wenigstens 80 Gew.-% EPA und DHA enthält
EP1107749B1 (de) Fumarsäurederivate zur behandlung der transplantatabstossung
DE69033560T2 (de) Arzneimittel für insulinresistente diabetiker
DE2845326C2 (de) Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
DE69718662T2 (de) Magnesium(-)hydroxycitrat, verfahren zur herstellung, anwendung und pharmazeutische zusammensetzungen, die sie enthalten
DE69713431T2 (de) Zubereitungen enthaltend l-carnitin oder derivate davon und antioxidations-mittel
DE3124090A1 (de) Neue orale dipyridamolformen
DD273197A5 (de) Verfahren zur herstellung eines omeprazol enthaltenden oralen pharmazeutischen praeparates
DE2749492C2 (de) Antithrombosemittel
DE3438821A1 (de) Verwendung von 24,25-dihydroxycholecalciferol
DE69619052T2 (de) Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung
DE3639378C2 (it)
EP0472501A2 (de) Codeinsalz einer substituierten Carbonsäure, Verfahren zu seiner Herstellung, seine Verwendung und pharmazeutische Präparate
DE3511609C2 (it)
LU86164A1 (de) Verfahren zu herstellung von isosilybinfreiem silibinin und arzneimittel,enthaltend silibinin
DE2921852A1 (de) Lipide senkendes mittel
DE69936307T2 (de) Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen
DE68915269T2 (de) Polyvalentes entzündungshemmendes mittel.
DE3410850A1 (de) Arzneimittel zum verstaerken von blutgefaessen und dessen verwendung
DE60025215T2 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
DE69918152T2 (de) Behandlung von verdauungsstörungen
DE2625053C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE3035494A1 (de) Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels
DE69413544T2 (de) Reduzierte absorption von fettsäuren

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection